Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by Lemoyneon Jan 13, 2021 11:24am
130 Views
Post# 32284846

RE:RE:RE:RE:RE:RE:Big Pharma and Nextleaf Solutions

RE:RE:RE:RE:RE:RE:Big Pharma and Nextleaf SolutionsExactly lol, they are late to the party. LABS has big pharma in its pocket already (It's a done deal), products shipping increasing. With its capabilities, it will snatch more big pharma CpG contracts before OILS gets its first local finished product contract.

OILS can't even produce finished products. It'll take money and time to get licenses and production lines/ tweaking those lines. by that time, LABS will be shipping millions of products every quarter.

Did I mention OILS is gonna have to dilute soon to be able to invest in licenses/ production lines? I think it's great time for OILS to dilute massively before Q4 earnings which might be a disaster considering the stock price hike it jusd had.

There goes their initial business plan (OILS) to be an extractor, they are realizing there is no growth there, 2 years late.
<< Previous
Bullboard Posts
Next >>